Cargando…
Cytochrome P450 2D6 genotype–phenotype characterization through population pharmacokinetic modeling of tedatioxetine
The cytochrome P450 (CYP) 2D6 enzyme exhibits large interindividual differences in metabolic activity. Patients are commonly assigned a CYP2D6 phenotype based on their CYP2D6 genotype, but there is a lack of consensus on how to translate genotypes into phenotypes, causing inconsistency in genotype‐b...
Autores principales: | Frederiksen, Trine, Areberg, Johan, Schmidt, Ellen, Stage, Tore Bjerregaard, Brøsen, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452298/ https://www.ncbi.nlm.nih.gov/pubmed/33932135 http://dx.doi.org/10.1002/psp4.12635 |
Ejemplares similares
-
Does ethnicity impact CYP2D6 genotype–phenotype relationships?
por: Frederiksen, Trine, et al.
Publicado: (2023) -
Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine
por: Frederiksen, Trine, et al.
Publicado: (2020) -
Estimating the In Vivo Function of CYP2D6 Alleles through Population Pharmacokinetic Modeling of Brexpiprazole
por: Frederiksen, Trine, et al.
Publicado: (2022) -
Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy
por: Dunvald, Ann-Cathrine Dalgård, et al.
Publicado: (2023) -
No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patients
por: Kuhlmann, Ida, et al.
Publicado: (2021)